Zentalis Pharmaceuticals, LLC (ZNTL)

Zentalis Pharmaceuticals (ZNTL) sees social dominance surge 150.77% as positive Phase [--] data for ZN-c3 fuels investor optimism. However, concerns linger regarding regulatory approval and manufacturing scale-up.

About Zentalis Pharmaceuticals, LLC

Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.
Zentalis Pharmaceuticals, LLC uses the ticker $ZNTL for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

• Zentalis Pharmaceuticals, LLC (ZNTL) social dominance hit [------] which is 189% higher than it's daily average.

Price: $2.40

Price 24-Hour Time-Series Raw Data
The stock price has seen a recent upward trend, likely driven by positive Phase [--] data for ZN-c3, indicating investor optimism. However, concerns about regulatory approval timelines and manufacturing scale-up may be limiting more substantial gains.

24-Hour: 2.14% 7-Day: 0.26% 30-Day: -19.26%

1-Year High: $3.70 on 2026-01-09
1-Year Low: $1.20 on 2025-06-30

AltRank: [-----]

AltRank 24-Hour Time-Series Raw Data
Zentalis Pharmaceuticals, LLC (ZNTL) is currently AltRank #1,700 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-01-28
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +1
1-Year High: [--] on 2026-02-03
1-Year Low: [--] on 2026-02-05

Engagements: [---] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -12%
[--] Month: [------] -79%
[--] Months: [-------] +47%
[--] Year: [-------] -61%
1-Year High: [------] on 2026-01-12
1-Year Low: [--] on 2025-09-07

Engagements by network (24h): Reddit: [--] YouTube: [--] X: [---] TikTok: [--]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -44%
1-Year High: [---] on 2026-01-11
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): Reddit: [--] YouTube: [--] X: [--] TikTok: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Zentalis Pharmaceuticals, LLC (ZNTL) in the last [--] hours which is down 59% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -37%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-12-07

Sentiment: 100%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 89%
[--] Week: 100% no change
[--] Month: 100% +16%
[--] Months: 100% no change
[--] Year: 100% no change
1-Year High: 100% on 2025-02-18
1-Year Low: 33% on 2025-05-29

Most Supportive Themes:

• Zentalis Pharmaceuticals Announces Positive Phase [--] Data for ZN-c3: (70%) Zentalis Pharmaceuticals LLC presented encouraging Phase [--] clinical trial results for their drug candidate ZN-c3, showing significant efficacy in treating certain types of cancer. The data has been met with enthusiasm from the oncology community and investors.
• Zentalis Expands Clinical Trial Pipeline with New Cancer Targets: (30%) The company is broadening its research and development efforts, initiating new clinical trials for ZN-c3 and other promising compounds targeting various advanced cancers. This expansion signals a commitment to addressing unmet medical needs.

Most Critical Themes:

• Regulatory Hurdles and Competition in Oncology Drug Development: (60%) Zentalis Pharmaceuticals faces a competitive landscape and stringent regulatory pathways for new cancer therapies. The success of ZN-c3 will depend on navigating these challenges effectively and demonstrating a clear advantage over existing treatments.
• Manufacturing Scale-Up and Supply Chain Considerations for ZN-c3: (40%) Ensuring a robust and scalable manufacturing process for ZN-c3 is crucial for its eventual market availability. Potential supply chain disruptions or manufacturing complexities could impact the drug's timely delivery to patients.

Social Dominance: 0.00143%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00143%
Daily Average: 0.00467%
[--] Week: 0.00162% -0.0002800000000000001%
[--] Month: 0.014% -0.0023%
[--] Months: 0.014% +0.012%
[--] Year: 0.014% +0.0058%
1-Year High: 0.061% on 2026-01-11
1-Year Low: 0.0002% on 2025-10-04

Market Dominance: 0.00017530143017276887%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00017530143017276887%
Daily Average: 0%
1-Year High: 0.00726% on 2026-01-13
1-Year Low: 0.00018% on 2026-02-16

Market Cap: $154,754,362

Market Cap 24-Hour Time-Series Raw Data
Current Value: $154,754,362
Daily Average: $174,568,100
[--] Week: $153,679,499 -0.44%
[--] Month: $154,754,362 -19%
1-Year High: $227,275,234 on 2026-01-14
1-Year Low: $143,099,222 on 2026-02-05

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing